Advertisement

Group purchasing organization Novation applauds the FDA's proposed unique device identifier program, but med-tech industry lobbying group AdvaMed wants to take a closer look to ensure the program avoid unnecessary burdens.

FDA UDI example

The FDA's UDI label example: Product name, expiration date, reference and lot nos., manufacturer information, barcode, details and illustration.

Medical tech industry stakeholders are showing mixed reactions to the FDA's latest proposal for a system of unique device identifiers that can monitor medical devices for tracking and public health purposes.

Group purchasing organization Novation applauded the FDA's effort, calling it a "significant milestone for patient safety," but representatives at industry lobby AdvaMed are taking a wary approach.

"We are reviewing the details of the proposed UDI rule and, after consultation with our members, will be submitting detailed comments," AdvaMed spokeswoman Wanda Moebius told reporters.

Advertisement
Advertisement